Evaluation of the effect of vitamin E in reducing the duration of treatment in children with gastroenteritis

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231119060105N1

Enrollment

Registered

2023-11-25

Start date

2023-10-01

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastroenteritis. Infectious gastroenteritis and colitis, unspecified

Interventions

Intervention group: intervention group In addition to routine treatment, which includes fluid therapy and ORS, receive vitamin E drops from "Bahsa" company, each milliliter of which contains 10 inter

Age 4-8 years: 21 drops equal to 1.05 ml

Age 9-13 years: 33 drops equal to 1.65 ml.

Eligibility

Sex/Gender

All

Age

1 Years to 13 Years

Inclusion criteria

Inclusion criteria: All children aged 1-13 years with acute gastroenteritis referred to Amirkabir Hospital, whose acute gastroenteritis was confirmed by a pediatric specialist based on the symptoms of diarrhea, vomiting, abdominal pain and dehydration. Informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Children who cannot tolerate oral vitamin E People who do not cooperate.

Design outcomes

Primary

Measure	Time frame
The effect of vitamin E on reducing the duration of diarrhea, vomiting, abdominal pain, fever, anorexia and dehydration in gastroenteritis patients.?. Timepoint: The beginning of the intervention and the end of symptoms. Method of measurement: Through history and questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ali Arjmand

Arak University of Medical Sciences

Aliarjmand1@yahoo.com+98 86 3313 4715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026